Business

Board and Committee Changes

capAI plc announced board changes with Jack Allardyce appointed as an Executive Director, replacing Richard Edwards, and Professor Ronjon Nag assuming the role of Executive Chairman. To incentivize Allardyce's appointment, the company granted him options over 8,166,667 ordinary shares with exercise prices of £0.00315 and £0.0001, totaling an aggregate value of £13,016.66, vesting on March 12, 2026. Richard Edwards will be treated as a good leaver, with accelerated vesting for two-thirds of his unvested options, while the remaining one-third will lapse. Disclaimer*

articleCapai PlcDecember 17, 20253/company/capai-plc/news/board-and-committee-changes-21
Board and Committee Changes

About this update from Capai Plc

[{"type":"text","content":"\n\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (\"UK\") PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) (\"UK MAR\"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n17 December 2025\n\ncapAI plc (the \"Company\" or \"capAI\")\nBoard and Committee Changes\ncapAI plc (LSE: CPAI) is pleased to announce that Jack Allardyce has been appointed to the board of directors of the Company (\"Board\") as an Executive Director. Jack Allardyce replaces Richard Edwards who has stepped down from the Board as an Executive Director after providing valuable insight and guidance to the Company over the last 14 months.\nJack Allardyce has over 20 years' experience in capital markets, corporate finance, executive leadership and stakeholder management. He has spent a decade as a leading UK equity research analyst with a number of investment banks and is both an experienced plc executive and advisor.\nWith immediate effect, Professor Ronjon Nag will assume the role of Executive Chairman of capAI, and the committees of the Board will be constitued as follows:\n\n\n\n\nCommittee\n\n\nChair\n\n\nOther members\n\n\n\n\nAudit & Risk Committee\n\n\nSarah Jane Davy\n\n\nJack Allardyce\nMarcus Yeoman\n\n\n\n\nDisclosure Committee\n\n\nJack Allardyce\n\n\nSarah Jane Davy\n\n\n\n\nNomination Committee\n\n\nMarcus Yeoman\n\n\nJack Allardyce\nSarah Jane Davy\n\n\n\n\nRemuneration Committee\n\n\nMarcus Yeoman\n\n\nSarah Jane Davy\n\n\n\n\nThe Company has accordingly granted options (\"Options\") over its ordinary shares of £0.0001 each in the capital of the Company (\"Ordinary Shares\") on the following terms, to incentivise Jack Allardyce on his appointment to the Board.\n\n\n\n\nGrant Date\n\n\nExercise Price\n\n\nNumber of Ordinary Shares\n\n\nVesting Dates\n\n\n\n\n17 December 2025\n\n\n£0.00315\n\n\n4,000,000\n\n\n12 March 2026\n\n\n\n\n17 December 2025\n\n\n£0.0001\n\n\n4,166,667\n\n\n12 March 2026\n\n\n\n\nComment\nProfessor Ronjon Nag, Executive Chairman of capAI, said:\n\"We are delighted to announce the appointment of Jack, positioning capAI for further success as we move into the ne...

More updates from Capai Plc